nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC6A3—nerve—multiple sclerosis	0.0223	0.126	CbGeAlD
Lisdexamfetamine—SLC6A2—nerve—multiple sclerosis	0.018	0.102	CbGeAlD
Lisdexamfetamine—SLC18A2—brainstem—multiple sclerosis	0.0126	0.0717	CbGeAlD
Lisdexamfetamine—SLC6A3—brainstem—multiple sclerosis	0.00956	0.0542	CbGeAlD
Lisdexamfetamine—SLC18A2—medulla oblongata—multiple sclerosis	0.00882	0.05	CbGeAlD
Lisdexamfetamine—SLC18A2—midbrain—multiple sclerosis	0.00806	0.0457	CbGeAlD
Lisdexamfetamine—SLC6A2—brainstem—multiple sclerosis	0.00772	0.0437	CbGeAlD
Lisdexamfetamine—ADRA1B—nervous system—multiple sclerosis	0.00669	0.0379	CbGeAlD
Lisdexamfetamine—SLC18A2—nervous system—multiple sclerosis	0.00662	0.0375	CbGeAlD
Lisdexamfetamine—ADRA1B—central nervous system—multiple sclerosis	0.00644	0.0365	CbGeAlD
Lisdexamfetamine—SLC18A2—central nervous system—multiple sclerosis	0.00638	0.0361	CbGeAlD
Lisdexamfetamine—SLC18A2—cerebellum—multiple sclerosis	0.00623	0.0353	CbGeAlD
Lisdexamfetamine—SLC6A3—midbrain—multiple sclerosis	0.00609	0.0345	CbGeAlD
Lisdexamfetamine—SLC6A3—spinal cord—multiple sclerosis	0.00595	0.0337	CbGeAlD
Lisdexamfetamine—SLC6A2—medulla oblongata—multiple sclerosis	0.00538	0.0305	CbGeAlD
Lisdexamfetamine—ADRA1B—brain—multiple sclerosis	0.00511	0.029	CbGeAlD
Lisdexamfetamine—SLC18A2—brain—multiple sclerosis	0.00506	0.0287	CbGeAlD
Lisdexamfetamine—SLC6A3—nervous system—multiple sclerosis	0.00501	0.0284	CbGeAlD
Lisdexamfetamine—SLC6A3—central nervous system—multiple sclerosis	0.00482	0.0273	CbGeAlD
Lisdexamfetamine—SLC6A3—cerebellum—multiple sclerosis	0.00472	0.0267	CbGeAlD
Lisdexamfetamine—SLC6A2—nervous system—multiple sclerosis	0.00404	0.0229	CbGeAlD
Lisdexamfetamine—SLC6A2—central nervous system—multiple sclerosis	0.00389	0.0221	CbGeAlD
Lisdexamfetamine—SLC6A3—brain—multiple sclerosis	0.00383	0.0217	CbGeAlD
Lisdexamfetamine—SLC6A2—brain—multiple sclerosis	0.00309	0.0175	CbGeAlD
Lisdexamfetamine—Weight decreased—Betamethasone—multiple sclerosis	0.00237	0.00288	CcSEcCtD
Lisdexamfetamine—Visual disturbance—Methotrexate—multiple sclerosis	0.00233	0.00283	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00232	0.00282	CcSEcCtD
Lisdexamfetamine—Convulsion—Mitoxantrone—multiple sclerosis	0.00231	0.0028	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.0023	0.00279	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.0023	0.00279	CcSEcCtD
Lisdexamfetamine—Hypertension—Mitoxantrone—multiple sclerosis	0.0023	0.00279	CcSEcCtD
Lisdexamfetamine—Hallucination—Methylprednisolone—multiple sclerosis	0.00229	0.00278	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Betamethasone—multiple sclerosis	0.00229	0.00278	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.00229	0.00278	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Cladribine—multiple sclerosis	0.00226	0.00275	CcSEcCtD
Lisdexamfetamine—Anxiety—Mitoxantrone—multiple sclerosis	0.00226	0.00275	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Methotrexate—multiple sclerosis	0.00225	0.00273	CcSEcCtD
Lisdexamfetamine—Visual impairment—Methylprednisolone—multiple sclerosis	0.00222	0.0027	CcSEcCtD
Lisdexamfetamine—Dizziness—Cladribine—multiple sclerosis	0.00219	0.00266	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00218	0.00264	CcSEcCtD
Lisdexamfetamine—Eye disorder—Methylprednisolone—multiple sclerosis	0.00215	0.00262	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00214	0.0026	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Azathioprine—multiple sclerosis	0.00213	0.00258	CcSEcCtD
Lisdexamfetamine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00212	0.00258	CcSEcCtD
Lisdexamfetamine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00211	0.00257	CcSEcCtD
Lisdexamfetamine—Irritability—Methotrexate—multiple sclerosis	0.0021	0.00256	CcSEcCtD
Lisdexamfetamine—Vomiting—Cladribine—multiple sclerosis	0.0021	0.00255	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.0021	0.00255	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Prednisone—multiple sclerosis	0.0021	0.00255	CcSEcCtD
Lisdexamfetamine—Rash—Cladribine—multiple sclerosis	0.00209	0.00253	CcSEcCtD
Lisdexamfetamine—Hallucination—Betamethasone—multiple sclerosis	0.00209	0.00253	CcSEcCtD
Lisdexamfetamine—Hallucination—Dexamethasone—multiple sclerosis	0.00209	0.00253	CcSEcCtD
Lisdexamfetamine—Dermatitis—Cladribine—multiple sclerosis	0.00208	0.00253	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00208	0.00253	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00208	0.00252	CcSEcCtD
Lisdexamfetamine—Weight increased—Prednisone—multiple sclerosis	0.00208	0.00252	CcSEcCtD
Lisdexamfetamine—Anorexia—Mitoxantrone—multiple sclerosis	0.00207	0.00252	CcSEcCtD
Lisdexamfetamine—Headache—Cladribine—multiple sclerosis	0.00207	0.00252	CcSEcCtD
Lisdexamfetamine—Weight decreased—Prednisone—multiple sclerosis	0.00206	0.00251	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisolone—multiple sclerosis	0.00206	0.0025	CcSEcCtD
Lisdexamfetamine—Depression—Prednisone—multiple sclerosis	0.00203	0.00246	CcSEcCtD
Lisdexamfetamine—Visual impairment—Dexamethasone—multiple sclerosis	0.00202	0.00245	CcSEcCtD
Lisdexamfetamine—Visual impairment—Betamethasone—multiple sclerosis	0.00202	0.00245	CcSEcCtD
Lisdexamfetamine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00202	0.00245	CcSEcCtD
Lisdexamfetamine—Malnutrition—Methylprednisolone—multiple sclerosis	0.00201	0.00244	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.002	0.00243	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisolone—multiple sclerosis	0.002	0.00243	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Prednisone—multiple sclerosis	0.00199	0.00242	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.00199	0.00241	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Azathioprine—multiple sclerosis	0.00198	0.00241	CcSEcCtD
Lisdexamfetamine—Nausea—Cladribine—multiple sclerosis	0.00197	0.00239	CcSEcCtD
Lisdexamfetamine—Eye disorder—Betamethasone—multiple sclerosis	0.00196	0.00238	CcSEcCtD
Lisdexamfetamine—Eye disorder—Dexamethasone—multiple sclerosis	0.00196	0.00238	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00194	0.00235	CcSEcCtD
Lisdexamfetamine—Somnolence—Mitoxantrone—multiple sclerosis	0.00193	0.00235	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00191	0.00233	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisolone—multiple sclerosis	0.00189	0.0023	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00189	0.0023	CcSEcCtD
Lisdexamfetamine—Hypertension—Prednisolone—multiple sclerosis	0.00189	0.00229	CcSEcCtD
Lisdexamfetamine—Fatigue—Mitoxantrone—multiple sclerosis	0.00188	0.00228	CcSEcCtD
Lisdexamfetamine—Constipation—Mitoxantrone—multiple sclerosis	0.00186	0.00226	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Azathioprine—multiple sclerosis	0.00184	0.00224	CcSEcCtD
Lisdexamfetamine—Angioedema—Triamcinolone—multiple sclerosis	0.00184	0.00223	CcSEcCtD
Lisdexamfetamine—Angioedema—Methylprednisolone—multiple sclerosis	0.00183	0.00223	CcSEcCtD
Lisdexamfetamine—Hallucination—Prednisone—multiple sclerosis	0.00182	0.00221	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00178	0.00217	CcSEcCtD
Lisdexamfetamine—Dizziness—Azathioprine—multiple sclerosis	0.00178	0.00216	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00176	0.00213	CcSEcCtD
Lisdexamfetamine—Convulsion—Triamcinolone—multiple sclerosis	0.00174	0.00212	CcSEcCtD
Lisdexamfetamine—Tachycardia—Prednisolone—multiple sclerosis	0.00174	0.00211	CcSEcCtD
Lisdexamfetamine—Convulsion—Methylprednisolone—multiple sclerosis	0.00174	0.00211	CcSEcCtD
Lisdexamfetamine—Hypertension—Triamcinolone—multiple sclerosis	0.00174	0.00211	CcSEcCtD
Lisdexamfetamine—Hypertension—Methylprednisolone—multiple sclerosis	0.00173	0.0021	CcSEcCtD
Lisdexamfetamine—Urticaria—Mitoxantrone—multiple sclerosis	0.00173	0.0021	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00173	0.00209	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00172	0.00209	CcSEcCtD
Lisdexamfetamine—Vomiting—Azathioprine—multiple sclerosis	0.00171	0.00208	CcSEcCtD
Lisdexamfetamine—Eye disorder—Prednisone—multiple sclerosis	0.00171	0.00207	CcSEcCtD
Lisdexamfetamine—Anxiety—Methylprednisolone—multiple sclerosis	0.0017	0.00207	CcSEcCtD
Lisdexamfetamine—Rash—Azathioprine—multiple sclerosis	0.0017	0.00206	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.0017	0.00206	CcSEcCtD
Lisdexamfetamine—Dermatitis—Azathioprine—multiple sclerosis	0.0017	0.00206	CcSEcCtD
Lisdexamfetamine—Depression—Methotrexate—multiple sclerosis	0.00169	0.00206	CcSEcCtD
Lisdexamfetamine—Headache—Azathioprine—multiple sclerosis	0.00169	0.00205	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00168	0.00205	CcSEcCtD
Lisdexamfetamine—Dry mouth—Triamcinolone—multiple sclerosis	0.00167	0.00203	CcSEcCtD
Lisdexamfetamine—Angioedema—Betamethasone—multiple sclerosis	0.00167	0.00202	CcSEcCtD
Lisdexamfetamine—Angioedema—Dexamethasone—multiple sclerosis	0.00167	0.00202	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Prednisone—multiple sclerosis	0.00165	0.002	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00164	0.00199	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00164	0.00199	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisolone—multiple sclerosis	0.00161	0.00196	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00161	0.00195	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00161	0.00195	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.0016	0.00195	CcSEcCtD
Lisdexamfetamine—Tachycardia—Triamcinolone—multiple sclerosis	0.0016	0.00194	CcSEcCtD
Lisdexamfetamine—Mental disorder—Prednisone—multiple sclerosis	0.0016	0.00194	CcSEcCtD
Lisdexamfetamine—Nausea—Azathioprine—multiple sclerosis	0.0016	0.00194	CcSEcCtD
Lisdexamfetamine—Tachycardia—Methylprednisolone—multiple sclerosis	0.0016	0.00194	CcSEcCtD
Lisdexamfetamine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00159	0.00193	CcSEcCtD
Lisdexamfetamine—Malnutrition—Prednisone—multiple sclerosis	0.00159	0.00193	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00159	0.00193	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00158	0.00192	CcSEcCtD
Lisdexamfetamine—Convulsion—Betamethasone—multiple sclerosis	0.00158	0.00192	CcSEcCtD
Lisdexamfetamine—Convulsion—Dexamethasone—multiple sclerosis	0.00158	0.00192	CcSEcCtD
Lisdexamfetamine—Hypertension—Dexamethasone—multiple sclerosis	0.00158	0.00191	CcSEcCtD
Lisdexamfetamine—Hypertension—Betamethasone—multiple sclerosis	0.00158	0.00191	CcSEcCtD
Lisdexamfetamine—Asthenia—Mitoxantrone—multiple sclerosis	0.00156	0.0019	CcSEcCtD
Lisdexamfetamine—Anxiety—Betamethasone—multiple sclerosis	0.00155	0.00188	CcSEcCtD
Lisdexamfetamine—Anxiety—Dexamethasone—multiple sclerosis	0.00155	0.00188	CcSEcCtD
Lisdexamfetamine—Hepatitis—Methotrexate—multiple sclerosis	0.00153	0.00185	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisone—multiple sclerosis	0.0015	0.00182	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00149	0.00181	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00149	0.00181	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00149	0.00181	CcSEcCtD
Lisdexamfetamine—Insomnia—Triamcinolone—multiple sclerosis	0.00148	0.0018	CcSEcCtD
Lisdexamfetamine—Insomnia—Methylprednisolone—multiple sclerosis	0.00148	0.0018	CcSEcCtD
Lisdexamfetamine—Visual impairment—Methotrexate—multiple sclerosis	0.00147	0.00179	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00146	0.00178	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00146	0.00177	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00146	0.00177	CcSEcCtD
Lisdexamfetamine—Agitation—Prednisone—multiple sclerosis	0.00146	0.00177	CcSEcCtD
Lisdexamfetamine—Tachycardia—Dexamethasone—multiple sclerosis	0.00145	0.00176	CcSEcCtD
Lisdexamfetamine—Tachycardia—Betamethasone—multiple sclerosis	0.00145	0.00176	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisone—multiple sclerosis	0.00145	0.00176	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Triamcinolone—multiple sclerosis	0.00144	0.00175	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Methotrexate—multiple sclerosis	0.00144	0.00175	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00144	0.00175	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00144	0.00175	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00144	0.00175	CcSEcCtD
Lisdexamfetamine—Eye disorder—Methotrexate—multiple sclerosis	0.00143	0.00173	CcSEcCtD
Lisdexamfetamine—Anorexia—Betamethasone—multiple sclerosis	0.00142	0.00172	CcSEcCtD
Lisdexamfetamine—Anorexia—Dexamethasone—multiple sclerosis	0.00142	0.00172	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisolone—multiple sclerosis	0.00142	0.00172	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00142	0.00172	CcSEcCtD
Lisdexamfetamine—Fatigue—Triamcinolone—multiple sclerosis	0.00141	0.00172	CcSEcCtD
Lisdexamfetamine—Fatigue—Methylprednisolone—multiple sclerosis	0.00141	0.00171	CcSEcCtD
Lisdexamfetamine—Vomiting—Mitoxantrone—multiple sclerosis	0.00138	0.00168	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Methotrexate—multiple sclerosis	0.00138	0.00167	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisone—multiple sclerosis	0.00138	0.00167	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00137	0.00167	CcSEcCtD
Lisdexamfetamine—Hypertension—Prednisone—multiple sclerosis	0.00137	0.00167	CcSEcCtD
Lisdexamfetamine—Rash—Mitoxantrone—multiple sclerosis	0.00137	0.00167	CcSEcCtD
Lisdexamfetamine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00137	0.00166	CcSEcCtD
Lisdexamfetamine—Headache—Mitoxantrone—multiple sclerosis	0.00136	0.00165	CcSEcCtD
Lisdexamfetamine—Anxiety—Prednisone—multiple sclerosis	0.00135	0.00164	CcSEcCtD
Lisdexamfetamine—Insomnia—Dexamethasone—multiple sclerosis	0.00135	0.00164	CcSEcCtD
Lisdexamfetamine—Insomnia—Betamethasone—multiple sclerosis	0.00135	0.00164	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00134	0.00163	CcSEcCtD
Lisdexamfetamine—Mental disorder—Methotrexate—multiple sclerosis	0.00134	0.00162	CcSEcCtD
Lisdexamfetamine—Malnutrition—Methotrexate—multiple sclerosis	0.00133	0.00161	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00131	0.0016	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00131	0.00159	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Betamethasone—multiple sclerosis	0.00131	0.00159	CcSEcCtD
Lisdexamfetamine—Urticaria—Triamcinolone—multiple sclerosis	0.0013	0.00158	CcSEcCtD
Lisdexamfetamine—Urticaria—Methylprednisolone—multiple sclerosis	0.0013	0.00158	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Triamcinolone—multiple sclerosis	0.0013	0.00158	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisone—multiple sclerosis	0.0013	0.00157	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Dexamethasone—multiple sclerosis	0.00129	0.00157	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Betamethasone—multiple sclerosis	0.00129	0.00157	CcSEcCtD
Lisdexamfetamine—Nausea—Mitoxantrone—multiple sclerosis	0.00129	0.00157	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00129	0.00156	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00129	0.00156	CcSEcCtD
Lisdexamfetamine—Fatigue—Dexamethasone—multiple sclerosis	0.00128	0.00156	CcSEcCtD
Lisdexamfetamine—Fatigue—Betamethasone—multiple sclerosis	0.00128	0.00156	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Prednisone—multiple sclerosis	0.00127	0.00154	CcSEcCtD
Lisdexamfetamine—Tachycardia—Prednisone—multiple sclerosis	0.00127	0.00154	CcSEcCtD
Lisdexamfetamine—Skin disorder—Prednisone—multiple sclerosis	0.00126	0.00153	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisone—multiple sclerosis	0.00125	0.00152	CcSEcCtD
Lisdexamfetamine—Vision blurred—Methotrexate—multiple sclerosis	0.00125	0.00152	CcSEcCtD
Lisdexamfetamine—Anorexia—Prednisone—multiple sclerosis	0.00124	0.0015	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00121	0.00147	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00121	0.00146	CcSEcCtD
Lisdexamfetamine—Urticaria—Dexamethasone—multiple sclerosis	0.00118	0.00144	CcSEcCtD
Lisdexamfetamine—Urticaria—Betamethasone—multiple sclerosis	0.00118	0.00144	CcSEcCtD
Lisdexamfetamine—Dizziness—Prednisolone—multiple sclerosis	0.00118	0.00143	CcSEcCtD
Lisdexamfetamine—Asthenia—Triamcinolone—multiple sclerosis	0.00118	0.00143	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Betamethasone—multiple sclerosis	0.00118	0.00143	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00118	0.00143	CcSEcCtD
Lisdexamfetamine—Asthenia—Methylprednisolone—multiple sclerosis	0.00117	0.00143	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisone—multiple sclerosis	0.00117	0.00142	CcSEcCtD
Lisdexamfetamine—Convulsion—Methotrexate—multiple sclerosis	0.00115	0.0014	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Prednisone—multiple sclerosis	0.00114	0.00139	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Prednisone—multiple sclerosis	0.00113	0.00137	CcSEcCtD
Lisdexamfetamine—Rash—Prednisolone—multiple sclerosis	0.00113	0.00137	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisolone—multiple sclerosis	0.00112	0.00137	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00112	0.00136	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00112	0.00136	CcSEcCtD
Lisdexamfetamine—Fatigue—Prednisone—multiple sclerosis	0.00112	0.00136	CcSEcCtD
Lisdexamfetamine—Headache—Prednisolone—multiple sclerosis	0.00112	0.00136	CcSEcCtD
Lisdexamfetamine—Constipation—Prednisone—multiple sclerosis	0.00111	0.00135	CcSEcCtD
Lisdexamfetamine—Dizziness—Triamcinolone—multiple sclerosis	0.00109	0.00132	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00108	0.00132	CcSEcCtD
Lisdexamfetamine—Dizziness—Methylprednisolone—multiple sclerosis	0.00108	0.00131	CcSEcCtD
Lisdexamfetamine—Asthenia—Betamethasone—multiple sclerosis	0.00107	0.0013	CcSEcCtD
Lisdexamfetamine—Asthenia—Dexamethasone—multiple sclerosis	0.00107	0.0013	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00106	0.00129	CcSEcCtD
Lisdexamfetamine—Nausea—Prednisolone—multiple sclerosis	0.00106	0.00129	CcSEcCtD
Lisdexamfetamine—Skin disorder—Methotrexate—multiple sclerosis	0.00105	0.00128	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00105	0.00127	CcSEcCtD
Lisdexamfetamine—Vomiting—Triamcinolone—multiple sclerosis	0.00104	0.00127	CcSEcCtD
Lisdexamfetamine—Vomiting—Methylprednisolone—multiple sclerosis	0.00104	0.00126	CcSEcCtD
Lisdexamfetamine—Rash—Triamcinolone—multiple sclerosis	0.00103	0.00126	CcSEcCtD
Lisdexamfetamine—Dermatitis—Triamcinolone—multiple sclerosis	0.00103	0.00126	CcSEcCtD
Lisdexamfetamine—Anorexia—Methotrexate—multiple sclerosis	0.00103	0.00125	CcSEcCtD
Lisdexamfetamine—Rash—Methylprednisolone—multiple sclerosis	0.00103	0.00125	CcSEcCtD
Lisdexamfetamine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00103	0.00125	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisone—multiple sclerosis	0.00103	0.00125	CcSEcCtD
Lisdexamfetamine—Headache—Triamcinolone—multiple sclerosis	0.00103	0.00125	CcSEcCtD
Lisdexamfetamine—Headache—Methylprednisolone—multiple sclerosis	0.00103	0.00125	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Prednisone—multiple sclerosis	0.00103	0.00124	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Dexamethasone—multiple sclerosis	0.00102	0.00124	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Betamethasone—multiple sclerosis	0.00102	0.00124	CcSEcCtD
Lisdexamfetamine—Dizziness—Dexamethasone—multiple sclerosis	0.000985	0.0012	CcSEcCtD
Lisdexamfetamine—Dizziness—Betamethasone—multiple sclerosis	0.000985	0.0012	CcSEcCtD
Lisdexamfetamine—Insomnia—Methotrexate—multiple sclerosis	0.00098	0.00119	CcSEcCtD
Lisdexamfetamine—Nausea—Triamcinolone—multiple sclerosis	0.000975	0.00118	CcSEcCtD
Lisdexamfetamine—Nausea—Methylprednisolone—multiple sclerosis	0.000973	0.00118	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Methotrexate—multiple sclerosis	0.000966	0.00117	CcSEcCtD
Lisdexamfetamine—Somnolence—Methotrexate—multiple sclerosis	0.000963	0.00117	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Prednisone—multiple sclerosis	0.000955	0.00116	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Methotrexate—multiple sclerosis	0.000954	0.00116	CcSEcCtD
Lisdexamfetamine—Vomiting—Dexamethasone—multiple sclerosis	0.000947	0.00115	CcSEcCtD
Lisdexamfetamine—Vomiting—Betamethasone—multiple sclerosis	0.000947	0.00115	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Methotrexate—multiple sclerosis	0.000942	0.00114	CcSEcCtD
Lisdexamfetamine—Rash—Betamethasone—multiple sclerosis	0.000939	0.00114	CcSEcCtD
Lisdexamfetamine—Rash—Dexamethasone—multiple sclerosis	0.000939	0.00114	CcSEcCtD
Lisdexamfetamine—Dermatitis—Betamethasone—multiple sclerosis	0.000938	0.00114	CcSEcCtD
Lisdexamfetamine—Dermatitis—Dexamethasone—multiple sclerosis	0.000938	0.00114	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000936	0.00114	CcSEcCtD
Lisdexamfetamine—Fatigue—Methotrexate—multiple sclerosis	0.000934	0.00113	CcSEcCtD
Lisdexamfetamine—Headache—Dexamethasone—multiple sclerosis	0.000933	0.00113	CcSEcCtD
Lisdexamfetamine—Headache—Betamethasone—multiple sclerosis	0.000933	0.00113	CcSEcCtD
Lisdexamfetamine—Asthenia—Prednisone—multiple sclerosis	0.00093	0.00113	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Prednisone—multiple sclerosis	0.000887	0.00108	CcSEcCtD
Lisdexamfetamine—Nausea—Betamethasone—multiple sclerosis	0.000885	0.00107	CcSEcCtD
Lisdexamfetamine—Nausea—Dexamethasone—multiple sclerosis	0.000885	0.00107	CcSEcCtD
Lisdexamfetamine—Urticaria—Methotrexate—multiple sclerosis	0.000861	0.00105	CcSEcCtD
Lisdexamfetamine—Dizziness—Prednisone—multiple sclerosis	0.000858	0.00104	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Methotrexate—multiple sclerosis	0.000857	0.00104	CcSEcCtD
Lisdexamfetamine—Vomiting—Prednisone—multiple sclerosis	0.000825	0.001	CcSEcCtD
Lisdexamfetamine—Rash—Prednisone—multiple sclerosis	0.000818	0.000993	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisone—multiple sclerosis	0.000817	0.000992	CcSEcCtD
Lisdexamfetamine—Headache—Prednisone—multiple sclerosis	0.000812	0.000986	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000798	0.00097	CcSEcCtD
Lisdexamfetamine—Asthenia—Methotrexate—multiple sclerosis	0.000778	0.000944	CcSEcCtD
Lisdexamfetamine—Nausea—Prednisone—multiple sclerosis	0.00077	0.000935	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Methotrexate—multiple sclerosis	0.000742	0.0009	CcSEcCtD
Lisdexamfetamine—Dizziness—Methotrexate—multiple sclerosis	0.000717	0.00087	CcSEcCtD
Lisdexamfetamine—Vomiting—Methotrexate—multiple sclerosis	0.000689	0.000837	CcSEcCtD
Lisdexamfetamine—Rash—Methotrexate—multiple sclerosis	0.000683	0.00083	CcSEcCtD
Lisdexamfetamine—Dermatitis—Methotrexate—multiple sclerosis	0.000683	0.000829	CcSEcCtD
Lisdexamfetamine—Headache—Methotrexate—multiple sclerosis	0.000679	0.000824	CcSEcCtD
Lisdexamfetamine—Nausea—Methotrexate—multiple sclerosis	0.000644	0.000782	CcSEcCtD
